Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOTCMKTS:ILIU
Date1/2003
Raised
Post IPO Valuation

General Information

Websiteilgenetics.com
CategoryHealth/Fitness
Phone781-398-0700
Emailpersonalized.heal...
Employees
Founded1999
DescriptionPersonalized health company

Offices

Waltham, USA
135 Beaver Street
Waltham, MA, 02452
USA

People

Chief Executive Officer, President and Chief Scientific Officer, Board of Directors
Chief Financial Officer, Treasurer
Chief Financial Officer
Board Director
Board Director
Board Director
Board Director
Board Director
Show All People

Funding

TOTAL $15M
FUNDING TOTAL $15M
Venture Round, 7/2012
Delta Dental
$3M
Private Equity, 5/2013
$12M

Tags

Interleukin Genetics

Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.

Recent Milestones

Videos

Screenshots

Interleukin Genetics screenshot
Above: Interleukin Genetics
Uploaded: 7/3/12

Stock Price

Sources

  1. Interleukin receives $3M in funding from Delta Dental (masshightech.com) [edit]
  2. Interleukin closes $12M private placement (bizjournals.com) [edit]
Edit This Page
Last Edited 3/23/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy